Lunit and SITC Launch Research Program for AI-Powered Cancer Immunotherapy Insights
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a strategic partnership with the Society for Immunotherapy of Cancer (SITC). This collaboration will launch the Lunit Research Program, granting SITC members access to Lunit SCOPE® IO, a powerful AI tool for quantitative immune phenotyping and tumor microenvironment (TME) analysis using H&E whole slide images (WSIs).
